STA R Max fully automatic clinical instrument designed to perform tests on human plasmas, Referen...

FDA Device Recall #Z-1575-2023 — Class II — March 22, 2023

Recall Summary

Recall Number Z-1575-2023
Classification Class II — Moderate risk
Date Initiated March 22, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Diagnostica Stago, Inc.
Location Parsippany, NJ
Product Type Devices
Quantity 6 analyzers

Product Description

STA R Max fully automatic clinical instrument designed to perform tests on human plasmas, Reference Numbers 59013 and 59026

Reason for Recall

An internal investigation identified a bug in this firmware version, resulting in the following:Intermittent shortened coagulation times and an increased frequency of occurrence of a technical error reported by the analyzer (error 13).

Distribution Pattern

US Nationwide distribution in the states of IL, MA, MN, NE, TX, and WI.

Lot / Code Information

UDI-DI: 036074505901; Serial Numbers: CP86010393 DB68093186 CP87010814 CP86070669 CP86090743 CP86090744

Other Recalls from Diagnostica Stago, Inc.

Recall # Classification Product Date
Z-1585-2026 Class II Brand Name: STA Liatest D-Di Product Name: STA... Feb 5, 2026
Z-1491-2026 Class II Brand Name: STA Liatest Free Protein S Product... Feb 4, 2026
Z-1084-2026 Class II Asserachrom HPIA. Model/Catalog Number: 00615... Dec 15, 2025
Z-0205-2026 Class II Product: STA Liatest D-Di; REF: 00515; Sep 12, 2025
Z-2473-2025 Class II STA Satellite. Product Code: All references. Al... Jul 21, 2025

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.